Cassava Sciences FLNA
Cassava Sciences Announces Full-year 2020 Financial Results and Business Highlights
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001171843-21-001982
- Document
- 8-K
- Exhibit 99.1
- Press release
- Reports quarterly results (2.02)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Anixa Biosciences ANIX public float $85M, Apr 30, 2025, over 18 months old
- GENELUX GNLX public float $89M, Jun 30, 2025
- Entera Bio ENTX public float $85M, Jun 30, 2025
- Immunic IMUX public float $83M, Jun 30, 2025
- Coherus Oncology CHRS public float $82M, Jun 30, 2025
